Bayer Investor Relations
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Our Q1 Statement
Bayer reports solid start to the year and confirms currency-adjusted Group guidance for 2026.
Quarterly Statements
Bayer publishes quarterly statements for the first and third quarter and half-year reports, including key financial figures.
Annual Reports
The integrated Annual Report combines our financial reporting and our nonfinancial statement.
Investor News
Read the latest press releases, investor updates, and important announcements from our company here.
Why Invest in Bayer?
The investment case provides a concise overview of the core business areas - Crop Science, Pharmaceuticals and Consumer Health - as well as current key metrics, innovation pipelines, and market opportunities for the year 2026.
Quarterly Reports Overview
Stock Chart
Experience the World of Bayer
Can´t find what you are looking for?
Explore our comprehensive investor resources. Access all key publications instantly in our download center, or reach out directly to our team for personalized assistance.